Incorrect Drug Name: In the Viewpoint titled "Imatinib - A New Tyrosine Kinase Inhibitor for First-Line Treatment of Chronic Myeloid Leukemia in 2015" published online March 12, 2015, in JAMA Oncology (doi:10.1001/jamaoncol.2015.50), an incorrect drug name appeared in the last sentence of the third paragraph. The drug name "nilotinib" should be replaced with "dasatinib." This article was corrected online.
GAMBACORTI PASSERINI, C., Piazza, R. (2015). Incorrect Drug Name. Imatinib--A New Tyrosine Kinase Inhibitor for First-Line Treatment of Chronic Myeloid Leukemia in 2015. JAMA ONCOLOGY, 1(2), 255-255 [10.1001/jamaoncol.2015.1156].
Incorrect Drug Name. Imatinib--A New Tyrosine Kinase Inhibitor for First-Line Treatment of Chronic Myeloid Leukemia in 2015
GAMBACORTI PASSERINI, CARLOPrimo
;PIAZZA, ROCCO GIOVANNIUltimo
2015
Abstract
Incorrect Drug Name: In the Viewpoint titled "Imatinib - A New Tyrosine Kinase Inhibitor for First-Line Treatment of Chronic Myeloid Leukemia in 2015" published online March 12, 2015, in JAMA Oncology (doi:10.1001/jamaoncol.2015.50), an incorrect drug name appeared in the last sentence of the third paragraph. The drug name "nilotinib" should be replaced with "dasatinib." This article was corrected online.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
